News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arsanis, Inc. Expands Its Anti-Infective Monoclonal Antibody Programs With Additional Grant Support From FFG and EUROSTARS



9/10/2012 9:16:14 AM

)--Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics against nosocomial infections. Both grant supports involve the Austrian Research Promotion Agency (Österr. Forschungsförderungs GmbH or “FFG”), the leading public funding agency for applied research in Austria.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES